Exhibit 21

Subsidiaries of Baxter International Inc.

		% owned by
		immediate
Subsidiary	Organized under laws of	parent (1)
Baxter International Inc.	Delaware
Baxter Healthcare Corporation	Delaware		100
Baxter Pharmaceutical Solutions LLC	Delaware		100
BioLife Plasma Services L.P.	Pennsylvania		99	(2)
Baxter World Trade Corporation	Delaware		100
Baxter Corporation	Canada		100
Baxter Export Corporation	Nevada		100
Baxter Sales and Distribution Corp.	Delaware		100	(3)
Baxter Healthcare Corporation of Puerto Rico	Alaska		100
Baxter Global Holdings II Inc.	Delaware		100
Baxter Holding B.V.	The Netherlands		100
Baxter Healthcare (Holdings) Limited	United Kingdom		100
Baxter Healthcare Limited	United Kingdom		100
Baxter Healthcare Holding GmbH	Switzerland		100
Baxter Handel GmbH	Switzerland		100
Baxter Healthcare SA	Switzerland		100
Baxter Trading GmbH	Switzerland		100
Baxter Innovations GmbH	Austria		100
Baxter AG	Austria		100
Baxter BioScience Manufacturing Sarl	Switzerland		100
Baxter Holdings LLC	Delaware		100
Baxter Mexico, S. de R.L. de C.V.	Mexico		99.9	(2)
Immuno Produtos Biologicos e Quimicos Ltda.	Brazil		99.999	(2)
Baxter Hospitalar Ltda.	Brazil		99.999	(2)
Baxter Netherlands Holding B.V.	The Netherlands		100
Baxter Deutschland Holding GmbH	Germany		94	(2)
Baxter Deutschland GmbH	Germany		100
Baxter S.A.	Belgium		99.64	(2)
Eczacibasi-Baxter Hastane Urunleri Sanayi ve Ticaret A.S.	Turkey		49.99	(4)
Baxter S.A.S.	France		64.58	(1)(2)
Baxter Travenol S.A.S.	France		99.98	(1)(2)
Baxter S.A.S.	France		35.42	(1)(2)
Baxter World Trade S.A.	Belgium		99.999	(2)
Baxter Holding Mexico, S. de R.L. de C.V.	Mexico		99.90	(2)
Baxter S.A. de C.V.	Mexico		99.9	(2)
Baxter Global Holdings Inc.	Delaware		100
Baxter Healthcare Pty Ltd	Australia		99.999	(2)
Baxter Healthcare (Asia) Pte Ltd	Singapore		100
Baxter Holdings Limited	Japan		100
Baxter Limited	Japan		100
Baxter Manufacturing S.p.A.	Italy		98.98	(2)
Bieffe Medital S.p.A.	Italy		99.30
Laboratorios Baxter S.A.	Delaware		100

Subsidiaries omitted from this list, considered in aggregate as a single subsidiary, would not constitute a significant subsidiary.

(1)	Including nominee shares.
(2)	Remaining shares owned by the Company, or other subsidiaries of the Company.
(3)	Of common stock, with preferred stock held by Baxter Healthcare Corporation.
(4)	Baxter’s ownership in this joint venture is 50%. The remaining .01% is owned by other Baxter entities.